van Strien Astrid M, Souverein Patrick C, Keijsers Carolina J P W, Heerdink Eibert R, Derijks Hieronymus J, van Marum Rob J
Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University.
J Clin Psychopharmacol. 2018 Aug;38(4):296-301. doi: 10.1097/JCP.0000000000000895.
Antipsychotic drugs are frequently prescribed to older adults, but they may be associated with serious adverse effects. The objective was to investigate the association between use of antipsychotics in older adults and the risk of urinary tract infections (UTIs).This study was designed as a cohort study.Data were obtained from the Clinical Practice Research Datalink from January 1, 2000, to September 29, 2016.Primary care patients 65 years or older in the United Kingdom with a first prescription for an oral antipsychotic were included in the study.Incidence of UTIs was calculated for periods with and without exposure to antipsychotic drugs in one cohort. Cox proportional hazard regression analysis with Andersen-Gill extension for recurrent events was used to calculate hazard ratios (HRs) with 95% confidence interval (CI).During the study period, 191,827 individuals with a first prescription for an oral antipsychotic drug were identified. Current use of antipsychotics was associated with an increased risk of UTI compared with past use (adjusted HR, 1.31; 95% CI, 1.28-1.34). This effect was strongest in the first 14 days of use (adjusted HR, 1.83; 95% CI, 1.73-1.95) and in individuals who used more than one antipsychotic drug concomitantly (adjusted HR, 1.64; 95% CI, 1.45-1.87). The risk was slightly higher for typical antipsychotics than for atypical antipsychotics. Stratification by sex showed that risk estimates were slightly higher in men than in women.Use of antipsychotics was associated with an increased risk of UTIs in both men and women, particularly in the first weeks after the start of treatment.
抗精神病药物经常被开给老年人,但它们可能会带来严重的副作用。目的是调查老年人使用抗精神病药物与尿路感染(UTIs)风险之间的关联。本研究设计为队列研究。数据取自2000年1月1日至2016年9月29日的临床实践研究数据链。研究纳入了英国65岁及以上首次开具口服抗精神病药物处方的初级保健患者。在一个队列中计算了暴露于抗精神病药物和未暴露于抗精神病药物期间的UTIs发病率。使用带有Andersen-Gill扩展的Cox比例风险回归分析来计算复发事件的风险比(HRs)及其95%置信区间(CI)。在研究期间,确定了191,827名首次开具口服抗精神病药物处方的个体。与过去使用相比,当前使用抗精神病药物与UTI风险增加相关(调整后的HR为1.31;95%CI为1.28 - 1.34)。这种效应在使用的前14天最强(调整后的HR为1.83;95%CI为1.73 - 1.95),并且在同时使用多种抗精神病药物的个体中(调整后的HR为1.64;95%CI为1.45 - 1.87)。典型抗精神病药物的风险略高于非典型抗精神病药物。按性别分层显示,男性的风险估计略高于女性。抗精神病药物的使用与男性和女性的UTIs风险增加相关,尤其是在治疗开始后的头几周。